Literature DB >> 28192976

Quantification of Influenza Neuraminidase Activity by Ultra-High Performance Liquid Chromatography and Isotope Dilution Mass Spectrometry.

Maria I Solano1, Adrian R Woolfitt1, Tracie L Williams1, Carrie L Pierce1, Larisa V Gubareva2, Vasiliy Mishin2, John R Barr1.   

Abstract

Mounting evidence suggests that neuraminidase's functionality extends beyond its classical role in influenza virus infection and that antineuraminidase antibodies offer protective immunity. Therefore, a renewed interest in the development of neuraminidase (NA)-specific methods to characterize the glycoprotein and evaluate potential advantages for NA standardization in influenza vaccines has emerged. NA displays sialidase activity by cleaving off the terminal N-acetylneuraminic acid on α-2,3 or α-2,6 sialic acid containing receptors of host cells. The type and distribution of these sialic acid containing receptors is considered to be an important factor in transmission efficiency of influenza viruses between and among host species. Changes in hemagglutinin (HA) binding and NA specificity in reassortant viruses may be related to the emergence of new and potentially dangerous strains of influenza. Current methods to investigate neuraminidase activity use small derivatized sugars that are poor models for natural glycoprotein receptors and do not provide information on the linkage specificity. Here, a novel approach for rapid and accurate quantification of influenza neuraminidase activity is achieved utilizing ultra-high performance liquid chromatography (UPLC) and isotope dilution mass spectrometry (IDMS). Direct LC-MS/MS quantification of NA-released sialic acid provides precise measurement of influenza neuraminidase activity over a range of substrates. The method provides exceptional sensitivity and specificity with a limit of detection of 0.38 μM for sialic acid and the capacity to obtain accurate measurements of specific enzyme activity preference toward α-2,3-sialyllactose linkages, α-2,6-sialyllactose linkages, or whole glycosylated proteins such as fetuin.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28192976      PMCID: PMC5695552          DOI: 10.1021/acs.analchem.6b04902

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  71 in total

1.  Difficulties in standardizing the neuraminidase content of influenza vaccines.

Authors:  L Gérentes; N Kessler; M Aymard
Journal:  Dev Biol Stand       Date:  1999

Review 2.  Critical review of current and emerging quantification methods for the development of influenza vaccine candidates.

Authors:  Aziza P Manceur; Amine A Kamen
Journal:  Vaccine       Date:  2015-08-10       Impact factor: 3.641

Review 3.  Transmission of influenza A viruses.

Authors:  Gabriele Neumann; Yoshihiro Kawaoka
Journal:  Virology       Date:  2015-03-24       Impact factor: 3.616

4.  Pandemic Swine H1N1 Influenza Viruses with Almost Undetectable Neuraminidase Activity Are Not Transmitted via Aerosols in Ferrets and Are Inhibited by Human Mucus but Not Swine Mucus.

Authors:  Mark Zanin; Bindumadhav Marathe; Sook-San Wong; Sun-Woo Yoon; Emily Collin; Christine Oshansky; Jeremy Jones; Benjamin Hause; Richard Webby
Journal:  J Virol       Date:  2015-03-25       Impact factor: 5.103

5.  The asparagine-linked oligosaccharides on bovine fetuin. Structural analysis of N-glycanase-released oligosaccharides by 500-megahertz 1H NMR spectroscopy.

Authors:  E D Green; G Adelt; J U Baenziger; S Wilson; H Van Halbeek
Journal:  J Biol Chem       Date:  1988-12-05       Impact factor: 5.157

6.  Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl-alpha-D-N-acetylneuraminate) substrate.

Authors:  M Potier; L Mameli; M Bélisle; L Dallaire; S B Melançon
Journal:  Anal Biochem       Date:  1979-04-15       Impact factor: 3.365

7.  Induction of partial immunity to influenza by a neuraminidase-specific vaccine.

Authors:  R B Couch; J A Kasel; J L Gerin; J L Schulman; E D Kilbourne
Journal:  J Infect Dis       Date:  1974-04       Impact factor: 5.226

8.  Balanced hemagglutinin and neuraminidase activities are critical for efficient replication of influenza A virus.

Authors:  L J Mitnaul; M N Matrosovich; M R Castrucci; A B Tuzikov; N V Bovin; D Kobasa; Y Kawaoka
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

9.  Human-specific regulation of alpha 2-6-linked sialic acids.

Authors:  Pascal Gagneux; Monica Cheriyan; Nancy Hurtado-Ziola; Els C M Brinkman van der Linden; Dan Anderson; Harold McClure; Ajit Varki; Nissi M Varki
Journal:  J Biol Chem       Date:  2003-09-18       Impact factor: 5.157

10.  Effect of cytochalasin B on the maturation of enveloped viruses.

Authors:  J A Griffin; R W Compans
Journal:  J Exp Med       Date:  1979-08-01       Impact factor: 14.307

View more
  5 in total

1.  Quantifying Carbohydrate-Active Enzyme Activity with Glycoprotein Substrates Using Electrospray Ionization Mass Spectrometry and Center-of-Mass Monitoring.

Authors:  Zhixiong Li; Pavel I Kitov; Elena N Kitova; Duong T Bui; Kelley W Moremen; Warren W Wakarchuk; Lara K Mahal; Matthew S Macauley; John S Klassen
Journal:  Anal Chem       Date:  2021-11-09       Impact factor: 6.986

2.  Evaluation of the potential defensive strategy against Influenza A in cell line models.

Authors:  Ekaterina Antonova; Olga Glazova; Anna Gaponova; Aykaz Eremyan; Natalya Grebenkina; Svetlana Zvereva; Natalya Volkova; Pavel Volchkov
Journal:  F1000Res       Date:  2018-02-19

Review 3.  The expanding role of mass spectrometry in the field of vaccine development.

Authors:  Vaneet Kumar Sharma; Ity Sharma; James Glick
Journal:  Mass Spectrom Rev       Date:  2018-05-31       Impact factor: 10.946

4.  Universal type/subtype-specific antibodies for quantitative analyses of neuraminidase in trivalent influenza vaccines.

Authors:  Kangwei Xu; Changgui Li; Caroline Gravel; Zheng Jiang; Bozena Jaentschke; Gary Van Domselaar; Xuguang Li; Junzhi Wang
Journal:  Sci Rep       Date:  2018-01-18       Impact factor: 4.379

Review 5.  NAction! How Can Neuraminidase-Based Immunity Contribute to Better Influenza Virus Vaccines?

Authors:  Florian Krammer; Ron A M Fouchier; Maryna C Eichelberger; Richard J Webby; Kathryn Shaw-Saliba; Hongquan Wan; Patrick C Wilson; Richard W Compans; Ioanna Skountzou; Arnold S Monto
Journal:  mBio       Date:  2018-04-03       Impact factor: 7.867

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.